Gregg Stone MD, FACC, FSCAI

Dr. Gregg W. Stone is an interventional cardiologist and Director of Academic Affairs for the Mount Sinai Heart Health System and a professor of Medicine (Cardiology) and Population Health Sciences and Policy. Dr. Stone has served as the national or international principal investigator for more than 120 national and international multicenter randomized trials (many of which have led to new device approval or indications in the US), has authored more than 2000 manuscripts and abstracts published in the peer-reviewed literature, and has delivered thousands of invited lectures around the world. With a 2018 H-factor of 152, Dr. Stone was recently listed in Nature Medicine as one of the most prolific authors in science.

Dr. Stone is the director of Transcatheter Cardiovascular Therapeutics (TCT), the world’s largest symposium devoted to interventional cardiology and vascular medicine. Dr. Stone founded the annual National Interventional Cardiology Fellow’s Course and co-directs multiple other meetings in the US, China, Russia, Europe, Korea, and elsewhere.

Dr. Stone previously was the Director of Cardiovascular Research and Education at Columbia University Medical Center/New York Presbyterian and Lenox Hill Hospitals in New York and the Washington Hospital Center in Washington, DC. Previously he was the Director of Interventional Cardiology at the Cardiovascular Institute at El Camino Hospital and Stanford University Medical Center in California.

Dr. Stone completed medical school at Johns Hopkins University Medical Center, in Baltimore, MD, and his internship and residency at the New York Hospital-Cornell Medical Center in New York City. He completed his general cardiology fellowship at Cedars-Sinai Medical Center in Los Angeles, CA, under Dr. Jeremy Swan, and subsequently a dedicated fellowship in advanced coronary angioplasty with Dr. Geoffrey O. Hartzler in Kansas City, MO.